Polygon Real Estate Ltd (TLV:POLY)

Akoya Biosciences Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	19.3	16.84	21.58	10.61	8.65
Depreciation & Amortization	5.33	5.35	5.45	5.57	4.96
Loss (Gain) From Sale of Investments	-	-	-	-4.08	-1.01
Other Operating Activities	1.77	-8.47	-12.32	1.53	1.86
Change in Accounts Receivable	0.39	1.56	1.88	-1.81	-2.64
Change in Accounts Payable	0.08	-0.32	0.07	0.19	-0.22
Change in Other Net Operating Assets	-3.86	0.99	-0.36	2.94	0.64
Operating Cash Flow	23.01	15.95	16.3	14.96	12.24
Operating Cash Flow Growth	44.26%	-2.14%	9.00%	22.21%	-2.00%
Capital Expenditures	-	-0.01	-	-	-
Sale (Purchase) of Real Estate	-0.02	-0.18	-1.05	-0.83	-0.89
Investment in Securities	-	0.46	8.72	-	-5.2
Other Investing Activities	-	5.09	14.17	-	-
Investing Cash Flow	-0.02	5.36	21.84	-0.83	-6.09
Short-Term Debt Repaid	-	-	-	-	-2.7
Long-Term Debt Repaid	-	-	-7	-6.42	-0.58
Total Debt Repaid	-	-	-7	-6.42	-3.28
Net Debt Issued (Repaid)	-	-	-7	-6.42	-3.28
Financing Cash Flow	-	-	-7	-6.42	-3.28
Net Cash Flow	22.99	21.32	31.14	7.7	2.87
Free Cash Flow	23.01	15.94	16.3	14.96	12.24
Free Cash Flow Growth	44.35%	-2.21%	9.00%	22.21%	-2.00%
Free Cash Flow Margin	76.70%	55.65%	60.99%	65.65%	62.39%
Free Cash Flow Per Share	4.47	3.10	3.17	2.91	2.38
Cash Interest Paid	-	-	0.58	0.06	0.19
Cash Income Tax Paid	3.52	8.19	4.94	1.99	0.84
Levered Free Cash Flow	17.42	14.74	16.89	13.59	11.37
Unlevered Free Cash Flow	17.43	14.75	17.04	13.78	11.57
Change in Net Working Capital	1.18	-0.23	-2.91	-1.69	0.23

Updated Aug 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.